Perhaps with interim CEO and his past experiences coupled with the fact of an announcement in the second quarter a favorable FDA approval will be announced.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.